Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pharmacological Reviews|February 13, 2023
Pharmacological Targeting of Mitochondria in Diabetic Kidney DiseaseKristan H Cleveland, Rick G Schnellmann
Molecular Pharmacology|June 4, 2026
Local protein kinase A signaling pathologies in the endocrine systemKristan H Cleveland, John D Scott
American Journal of Physiology. Renal Physiology|September 21, 2020
Regulation of mitochondrial dynamics and energetics in the diabetic renal proximal tubule by the β2-adrenergic receptor agonist formoterolKristan H Cleveland, Frank C Brosius, Rick G Schnellmann
The Journal of Pharmacology and Experimental Therapeutics|September 28, 2025
The β2-adrenoceptor agonist formoterol reverses metabolic dysfunction in the diabetic proximal tubuleKristan H Cleveland, Natalie E Scholpa, Rick G Schnellmann
The Journal of Pharmacology and Experimental Therapeutics|November 29, 2019
5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord InjuryEpiphani C Simmons, Natalie E Scholpa, Kristan H Cleveland, et al.
Molecular Carcinogenesis|April 8, 2018
Phosphoproteome profiling provides insight into the mechanism of action for carvedilol-mediated cancer preventionKristan H Cleveland, Steven Yeung, Kevin M Huang, et al.
The Journal of Biological Chemistry|April 8, 2025
The evolution of AKAPs and emergence of PKA isotype selective anchoring determinantsJerome I Falcone, Kristan H Cleveland, Mingu Kang, et al.
Plos One|May 21, 2019
Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptorsKristan H Cleveland, Sherry Liang, Andy Chang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 2, 2021
Prevention of Skin Carcinogenesis by the Non-β-blocking R-carvedilol EnantiomerSherry Liang, Md Abdullah Shamim, Ayaz Shahid, et al.
Pageof 2